Humans get parvo virus

Make sure you or your child gets plenty of rest and drinks lots of fluids. Acetaminophen Tylenol, others may help to relieve temperatures of more than F 39 C or minor aches and pains. Use caution when giving aspirin to children or teenagers. Though aspirin is approved for use in children older than age 3, children and teenagers recovering from chickenpox or flu-like symptoms should never take aspirin.

This is because aspirin has been linked to Reye's syndrome, a rare but potentially life-threatening condition, in such children. It's impractical and unnecessary to isolate your sick child. You won't know your child has parvovirus infection until the rash appears, and by that time, your child is no longer contagious. Most people with parvovirus infection don't seek medical attention.

You may want to talk to your family doctor if you or your child has been exposed to parvovirus and has an underlying condition that increases the risk of complications. During the physical examination, your doctor will pay special attention to any skin rashes.

If you're a female past puberty, your doctor may ask if there's any chance you're pregnant. Mayo Clinic does not endorse companies or products.

Skip directly to site content Skip directly to page options Skip directly to A-Z link. Parvovirus B19 and Fifth Disease. Section Navigation. Facebook Twitter LinkedIn Syndicate. Minus Related Pages. By the time the rash appears, the child is ususally better and no longer infectious. For the most part, it is relatively a mild infection.

In adults, it can cause an inflammatory arthritis that looks very much like rheumatoid arthritis. Adults often lack the fever and rash.

Corbett, T. Saw, U. Popat, E. MacMahon, B. Cohen, W. Knowles, S. Beard, and H. Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant. Bone Marrow Transplant. Corcoran, A. Doyle, D. Waldron, A. Nicholson, and B.

Impaired gamma interferon responses against parvovirus B19 by recently infected children. Corral, D. Darras, C. Jensen, T. Hakala, S. Naides, J. Krause, T. Starzl, and M. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. Transplantation 55 : Cossart, Y.

Field, B. Cant, and D. Parvovirus-like particles in human sera. Lancet i : Cotmore, S. Nuesch, and P. McKie, L. Anderson, C. Astell, and P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. Coulombel, L. Morinet, F. Mielot, and G. Parvovirus infection, leukemia, and immunodeficiency.

Crook, T. Rogers, R. McFarland, S. Kroft, P. Muretto, J. Hernandez, M. Latimer, and R. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Deiss, V. Tratschin, M. Weitz, and G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Diaz, F. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection.

Dijkmans, B. Salimans, G. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum. Doerig, C. Hirt, J. Antonietti, and P. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. Doran, H. Neutropenia accompanying erythroid aplasia in human parvovirus infection. Dorsch, S. Kaufmann, U. Schaible, E. Prohaska, H. Wolf, and S. The VP1-unique region of parvovirus B amino acid variability and antigenic stability. Duncan, J. Potter, M.

Cappellini, J. Kurtz, M. Anderson, and D. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Durigon, E. Erdman, G. Gary, M. Pallansch, T. Torok, and L. Methods 44 : Eis-Hubinger, A. Dieck, R. Schild, M. Hansmann, and K. Parvovirus B19 infection in pregnancy. Intervirology 41 : Enders, G. Parvovirus B19 infections in pregnancy. Dotsch, J. Bauer, W. Nutzenadel, H. Hengel, D. Haffner, G. Schalasta, K. Searle, and K. Life-threatening parvovirus Bassociated myocarditis and cardiac transplantation as possible therapy: two case reports.

Erdman, D. Anderson, T. Torok, T. Finkel, and L. Possible transmission of parvovirus B19 from intravenous immune globulin. Durigon, Q. Wang, and L. Usher, C. Tsou, E. Caul, G. Gary, S. Kajigaya, N. Young, and L. Ergas, D. Resnitzky, and A. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia.

Blood 87 : Essary, L. Vnencak-Jones, S. Manning, S. Olson, and J. Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods. Evans, J. Rossiter, T. Kumaran, G. Marsh, and P. Human parvovirus aplasia: case due to cross infection in a ward. Fisher, D. Spencer, H. Iland, S. Brammah, and Y. Red cell aplasia caused by human parvovirus B19 in acute leukaemia.

Reference deleted. Forestier, F. Tissot, Y. Vial, F. Daffos, and P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Foto, F. Saag, L. Scharosch, E. Howard, and S. Franssila, R. Hokynar, and K. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b Frickhofen, N.

Abkowitz, M. Safford, J. Berry, J. Antunez-de-Mayolo, A. Astrow, R. Cohen, I. Halperin, L. King, and D. Arnold, B. Hertenstein, M. Wiesneth, and N. Parvovirus B19 infection and bone marrow transplantation. Chen, N. Cohen, H. Heimpel, and J. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Fujita, H. Takada, K. Kuremoto, K. Ishimoto, N. Sato, A. Tsuji, H. Yoshida, M. Kaneko, H. Hirai, and T. Human parvovirus B19 infection in patients with hematologic disorders on chemotherapy.

Rinsho Ketsueki 34 : In Japanese. Fuller, A. Moaven, D. Spelman, W. Spicer, H. Wraight, D. Curtis, J. Leydon, J. Doultree, and S.

Parvovirus B19 in HIV infection: a treatable cause of anemia. Pathology 28 : Gahr, M. Pekrun, and H. Persistence of parvovirus BDNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Gigler, A. Dorsch, A. Hemauer, C. Williams, S. Kim, N. Young, S. Zolla-Pazner, H. Wolf, M. Gorny, and S. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.

Gillespie, S. Cartter, S. Asch, J. Rokos, G. Gary, C. Tsou, D. Hall, L. Anderson, and E. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA : Graeve, J. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease.

Gray, J. Cohen, and U. Detection of human parvovirus Bspecific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. Green, S. Malkovska, M. O'Sullivan, and K. Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the erythrovirus genus in monkeys. Guidozzi, F. Ballot, and A. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.

Hanada, T. Koike, C. Hirano, T. Takeya, T. Suzuki, Y. Matsunaga, and H. Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Koike, T. Nagasawa, Y. Human parvovirus Binduced transient pancytopenia in a child with hereditary spherocytosis. Yamamura, T. Isobe, M. Nakazawa, T. Abe, and H. Pure red cell aplasia in association with malignant histiocytosis. Cancer 57 : Harel, L. Straussberg, H.

Rudich, A. Cohen, and J. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes. Harger, J. Adler, W. Koch, and G. Prospective evaluation of pregnant women exposed to parvovirus B risks and symptoms.

Harris, J. Parvovirus B19 for the hematologist. Hasle, H. Heegaard, G. Kerndrup, I. Jensen, N. Peterslund, and A. Parvovirus B19 infection infrequently involved in children and adults with myelodysplastic syndrome. Kerndrup, B.